HOHMANN JOHN,CUTSHALL NEIL S,ZENG HONGKUI,GAITANARIS GEORGE,BERGMANN JOHN E,ONRUST RENE,DEMOPULOS GREGORY A,GRAY PATRICK,FLORIO VINCENT A
申请号：
NZ62180610
公开号：
NZ621806A
申请日:
2010.05.03
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is the use of PDE7 inhibitors that have a benzopyrimidine core with a spiro carbocycle for treating a movement abnormality associated with the pathology of a neurological disorder in a patient. Specific examples of neurological movement disorders include Parkinson&rsquos disease, Post-Encephalitic Parkinsonism, Dopamine Responsive Dystonia, Shy-Drager Syndrome, Periodic Limb Movement Disorder (PLMD), Periodic Limb Movements in Sleep (PLMS), Tourette&rsquos Syndrome, and Restless Leg(s) Syndrome (RLS).
